← Back to headlines
US FDA Proposes Curbs on Mass Compounding of Weight-Loss Drugs
The U.S. FDA has proposed new restrictions on the mass compounding of weight-loss drugs manufactured by Novo Nordisk and Eli Lilly.
30 Apr, 17:56 — 30 Apr, 17:56
Sources
Showing 1 of 1 sources
Related Stories
Trump Considers Military Action Against Iran Amid Hormuz Blockade Discussions; UK Declines to Join
just now
Philippine Senator Dela Rosa Reportedly Heeding Lacson's 'Advice' on Hiding
just now
Plunder and Graft Raps Filed Against Jinggoy Estrada Over Flood Control Scam
just now
Senator Jinggoy Estrada Charged with Plunder Over Budget Irregularities
just now